EWA
TNXP icon

EverSource Wealth Advisors’s Tonix Pharmaceuticals TNXP Stock Holding History

EverSource Wealth Advisors’s Portfolio TNXP Stock Details TNXP Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$15K Buy
1,173
+797
+212% +$10.3K ﹤0.01% 2649
2026
Q1 		$5.17K Buy
376
+375
+37,500% +$5.77K ﹤0.01% 3255
2025
Q4 		$16 Buy
+1
New +$18 ﹤0.01% 4229

Other funds holding TNXP

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Point72 Asset Management
Point72 Asset Management Stamford, Connecticut $90.7B AUM 77.13% 1-Year Est. Return
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $287B AUM 42.33% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
JHC
Jones Hill Capital New York $470M AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
II
Ishara Investments Los Angeles, California $136M AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return

EverSource Wealth Advisors's TNXP Position: Q2 2026 in Review

EverSource Wealth Advisors increased its Tonix Pharmaceuticals (TNXP) stake by 212% in Q2 2026, buying an estimated $10.3K and bringing the position to 1,173 shares worth $15K. The position accounts for ﹤0.01% of the portfolio, ranked #2649.

EverSource Wealth Advisors first reported a position in TNXP in Q4 2025 and has held it in 3 quarters since. 103 funds tracked by Wall St. Rank hold TNXP as of Q2 2026.

  • EverSource Wealth Advisors held 1,173 shares of Tonix Pharmaceuticals worth $15K as of Q2 2026.
  • EverSource Wealth Advisors bought 797 Tonix Pharmaceuticals shares in Q2 2026, an estimated $10.3K.
  • Tonix Pharmaceuticals made up ﹤0.01% of EverSource Wealth Advisors's portfolio in Q2 2026, its #2649 holding.
  • EverSource Wealth Advisors first reported a position in Tonix Pharmaceuticals in Q4 2025 and has held it in 3 quarters since.
  • 103 funds tracked by Wall St. Rank held Tonix Pharmaceuticals as of Q2 2026.

Based on EverSource Wealth Advisors's 13F filing for Q2 2026, filed 24 Jul 2026.